On the recordApril 25, 2022
Congress charged the FDA, not CMS, to be the agency responsible for evaluating the safety and efficacy of biomedical products.
Source
congress.govEditor's note · Context
Senator Collins emphasizes FDA's primary role in evaluating biomedical product safety.
Share
More from Susan Collins
Jul 14, 2026
While it is clear ICE needs to improve its performance, it is important to remember that the work ICE does to protect our country goes far beyond immigration enforcement.
Jun 24, 2026
It surprises me. I understand that people are having a difficult time right now economically. That’s why I’ve worked so hard to bring $1.5 billion back to the state of Maine during the past five years.
Jun 14, 2026
I know that there's some people who want me to oppose President Trump, just because he's President Trump, and that's not how I operate.
Jul 15, 2026
It would be wise for DHS to have a halt in non-urgent traffic stops until we get this straightened out.
Other voices in this conversation
